Biotech Ethics Council Urged By Former FDAer/AdvaMed VP Benson
This article was originally published in The Gray Sheet
Executive Summary
An advisory panel should be created to consider moral and ethical biotechnology issues faced by FDA and other health agencies, according to former FDA Acting Commissioner James Benson
You may also be interested in...
CBER Director Zoon Leaving FDA, Will Assume Position At NCI In January
Center for Biologics Evaluation & Research Director Kathryn Zoon's January departure coincides with the establishment of the FDA office of combination products under MDUFMA
Research Regulations Draft Report To Be Completed By April 2003 – PCB
A draft report by the President's Council on Bioethics expected to address regulation of pre-implantation genetic testing and diagnosis will be completed before the council meets in April 2003, PCB said during a meeting held Oct. 17-18 in Washington, D.C
FDA Categorization Of Hybrid Medical Products Suggested By Science Board
FDA should consider developing a system to categorize hybrid technologies that would help the agency evaluate which products might raise ethical concerns, FDA Science Board panel members recommended.